- Industry Outlook: “How the Evolving Healthcare Delivery System is Changing Medtech’s Mindset,” by Stephen Levin
- Technology Trends: “Myoscience: The Promise of Cold Therapy,” by David Cassak
- Under the Lens: “Sunshine Heart: A First-Mover in Earlier-Stage Heart Failure,” by Mary Thompson
- Market Snapshot: “In a Mature Knee/Hip Implant Market, 2% Growth Looks Dapper,” by Wendy Diller
- Start-Ups to Watch:
– “RainDance Technologies: Converting Biology to Big Data,” by Wendy Diller
– “Figure 8 Surgical: Advancing Sternotomy Closure, Reducing Complications,” by Mary Stuart
– “Intelomed: Noninvasive, Predictive Hemodynamic Monitor Gives Early Alert to Prevent Cardiovascular Events,” by Mary Stuart
Industry Outlook: “How the Evolving Healthcare Delivery System is Changing Medtech’s Mindset”
by Stephen Levin
This diverse expert panel at Innovation In Medtech’s EMT Summit conference highlights how the medical device industry is not immune from the systemic changes healthcare is undergoing, and product companies need to be learning this new set of rules.
Technology Trends: “Myoscience: The Promise of Cold Therapy”
By David Cassak
Cold therapy has a spotty history in medtech in treating serious conditions. Can Myoscience’s novel approach, which focuses on nerves, finally unleash the potential of cold-based treatments?
Boston Scientific Corp. – CR Bard – Myoscience Inc. – Zoll Medical Corp.
Under the Lens: “Sunshine Heart: A First-Mover in Earlier-Stage Heart Failure”
By Mary Thompson
Filling the treatment gap for Class III heart failure patients is a huge challenge, but also a huge potential opportunity for device manufacturers. One company hoping to tap the wellspring is Sunshine Heart, a first-mover in the market for earlier-stage cardiac assist devices. As the lone clinical pioneer in this space, the company has faced substantial hurdles, but now sees positive momentum on its side.
The stage appears set for a modest rebound in the hip and knee replacement markets, although pricing pressures remain.
Biomet Inc. – Johnson/Johnson – Smith & Nephew Inc. – Stryker Corp. – Zimmer Inc.
Start-Ups to Watch: “RainDance Technologies: Converting Biology to Big Data”
By Wendy Diller
RainDance’s platform of ultra-sensitive liquid biopsy genomic tools represents a fundamental breakthrough in detection and monitoring of complex diseases.
Start-Ups to Watch: “Figure 8 Surgical: Advancing Sternotomy Closure, Reducing Complications”
By Mary Stuart
The standard method for sternal closure hasn’t advanced in 50 years, but today’s heart surgery patients are more complicated. Figure 8 Surgical aims to help avoid complications with a primary closure device that improves upon steel wire.
Acute Innovation LLC – Dallen Medical Inc. – Figure 8 Surgical Inc. – Johnson & Johnson/Synthes – RTI Surgical Inc.
Start-Ups to Watch: “Intelomed: Noninvasive, Predictive Hemodynamic Monitor Gives Early Alert to Prevent Cardiovascular Events”
By Mary Stuart
Hemodynamic monitoring tools for dialysis, heart failure, and other patients experiencing stresses to the heart don’t always provide alerts soon enough for clinicians to head off hospitalizations. That’s where Intelomed hopes to shine.
Edwards Lifesciences Corp. – Intelomed Inc. – St. Jude Medical Inc.